vs
Astrana Health, Inc.（ASTH）与百通（BDC）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是百通的1.4倍（$950.5M vs $696.4M），百通净利率更高（7.3% vs 0.7%，领先6.6%），Astrana Health, Inc.同比增速更快（42.9% vs 11.4%），Astrana Health, Inc.自由现金流更多（$-6.0M vs $-63.1M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 7.3%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
百通公司是美国上市跨国企业，专注于端到端网络、安全及连接产品的设计、生产与销售，业务覆盖工业自动化解决方案、智能建筑、宽带及5G三大核心领域，为各行业客户提供可靠的通信连接相关产品与服务。
ASTH vs BDC — 直观对比
营收规模更大
ASTH
是对方的1.4倍
$696.4M
营收增速更快
ASTH
高出31.4%
11.4%
净利率更高
BDC
高出6.6%
0.7%
自由现金流更多
ASTH
多$57.1M
$-63.1M
两年增速更快
ASTH
近两年复合增速
7.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $696.4M |
| 净利润 | $6.6M | $51.0M |
| 毛利率 | — | 37.1% |
| 营业利润率 | 1.9% | 11.2% |
| 净利率 | 0.7% | 7.3% |
| 营收同比 | 42.9% | 11.4% |
| 净利润同比 | 184.4% | -1.8% |
| 每股收益（稀释后） | $0.12 | $1.30 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHBDC
| Q1 26 | — | $696.4M | ||
| Q4 25 | $950.5M | $720.1M | ||
| Q3 25 | $956.0M | $698.2M | ||
| Q2 25 | $654.8M | $672.0M | ||
| Q1 25 | $620.4M | $624.9M | ||
| Q4 24 | $665.2M | $666.0M | ||
| Q3 24 | $478.7M | $654.9M | ||
| Q2 24 | $486.3M | $604.3M |
净利润ASTHBDC
| Q1 26 | — | $51.0M | ||
| Q4 25 | $6.6M | $67.9M | ||
| Q3 25 | $373.0K | $56.7M | ||
| Q2 25 | $9.4M | $61.0M | ||
| Q1 25 | $6.7M | $51.9M | ||
| Q4 24 | $-7.8M | $58.4M | ||
| Q3 24 | $16.1M | $53.7M | ||
| Q2 24 | $19.2M | $49.0M |
毛利率ASTHBDC
| Q1 26 | — | 37.1% | ||
| Q4 25 | — | 36.6% | ||
| Q3 25 | — | 37.7% | ||
| Q2 25 | — | 38.5% | ||
| Q1 25 | — | 39.3% | ||
| Q4 24 | — | 37.5% | ||
| Q3 24 | — | 37.3% | ||
| Q2 24 | — | 37.5% |
营业利润率ASTHBDC
| Q1 26 | — | 11.2% | ||
| Q4 25 | 1.9% | 12.2% | ||
| Q3 25 | 2.0% | 10.9% | ||
| Q2 25 | 3.1% | 11.8% | ||
| Q1 25 | 3.3% | 11.6% | ||
| Q4 24 | 0.1% | 10.4% | ||
| Q3 24 | 5.9% | 11.5% | ||
| Q2 24 | 6.2% | 11.4% |
净利率ASTHBDC
| Q1 26 | — | 7.3% | ||
| Q4 25 | 0.7% | 9.4% | ||
| Q3 25 | 0.0% | 8.1% | ||
| Q2 25 | 1.4% | 9.1% | ||
| Q1 25 | 1.1% | 8.3% | ||
| Q4 24 | -1.2% | 8.8% | ||
| Q3 24 | 3.4% | 8.2% | ||
| Q2 24 | 3.9% | 8.1% |
每股收益（稀释后）ASTHBDC
| Q1 26 | — | $1.30 | ||
| Q4 25 | $0.12 | $1.70 | ||
| Q3 25 | $0.01 | $1.41 | ||
| Q2 25 | $0.19 | $1.53 | ||
| Q1 25 | $0.14 | $1.27 | ||
| Q4 24 | $-0.14 | $1.41 | ||
| Q3 24 | $0.33 | $1.30 | ||
| Q2 24 | $0.40 | $1.19 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $272.2M |
| 总债务越低越好 | — | $1.3B |
| 股东权益账面价值 | $779.3M | $1.3B |
| 总资产 | $2.2B | — |
| 负债/权益比越低杠杆越低 | — | 0.98× |
8季度趋势，按日历期对齐
现金及短期投资ASTHBDC
| Q1 26 | — | $272.2M | ||
| Q4 25 | $429.5M | $389.9M | ||
| Q3 25 | $463.4M | $314.3M | ||
| Q2 25 | $342.1M | $301.5M | ||
| Q1 25 | $260.9M | $259.0M | ||
| Q4 24 | $290.8M | $370.3M | ||
| Q3 24 | $350.3M | $323.0M | ||
| Q2 24 | $327.7M | $564.8M |
总债务ASTHBDC
| Q1 26 | — | $1.3B | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益ASTHBDC
| Q1 26 | — | $1.3B | ||
| Q4 25 | $779.3M | $1.3B | ||
| Q3 25 | $775.5M | $1.2B | ||
| Q2 25 | $765.5M | $1.2B | ||
| Q1 25 | $745.4M | $1.2B | ||
| Q4 24 | $712.7M | $1.3B | ||
| Q3 24 | $704.6M | $1.2B | ||
| Q2 24 | $678.9M | $1.2B |
总资产ASTHBDC
| Q1 26 | — | — | ||
| Q4 25 | $2.2B | $3.5B | ||
| Q3 25 | $2.2B | $3.4B | ||
| Q2 25 | $1.4B | $3.4B | ||
| Q1 25 | $1.3B | $3.3B | ||
| Q4 24 | $1.4B | $3.3B | ||
| Q3 24 | $1.3B | $3.3B | ||
| Q2 24 | $1.3B | $3.5B |
负债/权益比ASTHBDC
| Q1 26 | — | 0.98× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | — |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $-63.1M |
| 自由现金流率自由现金流/营收 | -0.6% | -9.1% |
| 资本支出强度资本支出/营收 | 0.3% | 6.4% |
| 现金转化率经营现金流/净利润 | -0.44× | — |
| 过去12个月自由现金流最近4个季度 | $104.5M | $180.4M |
8季度趋势，按日历期对齐
经营现金流ASTHBDC
| Q1 26 | — | — | ||
| Q4 25 | $-2.9M | $160.4M | ||
| Q3 25 | $10.0M | $105.0M | ||
| Q2 25 | $90.9M | $82.0M | ||
| Q1 25 | $16.6M | $7.4M | ||
| Q4 24 | $-10.9M | $174.7M | ||
| Q3 24 | $34.0M | $91.7M | ||
| Q2 24 | $23.2M | $83.0M |
自由现金流ASTHBDC
| Q1 26 | — | $-63.1M | ||
| Q4 25 | $-6.0M | $121.3M | ||
| Q3 25 | $7.4M | $65.3M | ||
| Q2 25 | $89.5M | $56.9M | ||
| Q1 25 | $13.6M | $-24.8M | ||
| Q4 24 | $-13.5M | $116.4M | ||
| Q3 24 | $31.7M | $67.2M | ||
| Q2 24 | $20.4M | $61.0M |
自由现金流率ASTHBDC
| Q1 26 | — | -9.1% | ||
| Q4 25 | -0.6% | 16.8% | ||
| Q3 25 | 0.8% | 9.4% | ||
| Q2 25 | 13.7% | 8.5% | ||
| Q1 25 | 2.2% | -4.0% | ||
| Q4 24 | -2.0% | 17.5% | ||
| Q3 24 | 6.6% | 10.3% | ||
| Q2 24 | 4.2% | 10.1% |
资本支出强度ASTHBDC
| Q1 26 | — | 6.4% | ||
| Q4 25 | 0.3% | 5.4% | ||
| Q3 25 | 0.3% | 5.7% | ||
| Q2 25 | 0.2% | 3.7% | ||
| Q1 25 | 0.5% | 5.2% | ||
| Q4 24 | 0.4% | 8.8% | ||
| Q3 24 | 0.5% | 3.7% | ||
| Q2 24 | 0.6% | 3.6% |
现金转化率ASTHBDC
| Q1 26 | — | — | ||
| Q4 25 | -0.44× | 2.36× | ||
| Q3 25 | 26.69× | 1.85× | ||
| Q2 25 | 9.65× | 1.34× | ||
| Q1 25 | 2.48× | 0.14× | ||
| Q4 24 | — | 2.99× | ||
| Q3 24 | 2.11× | 1.71× | ||
| Q2 24 | 1.21× | 1.69× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
BDC
暂无分部数据
